Total Payments
$8,743
2024 Payments
$3,687
Companies
34
Transactions
493
Medicare Patients
462
Medicare Billing
$37,160
Payment Breakdown by Category
Food & Beverage$8,719 (99.7%)
Education$24.39 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,719 | 492 | 99.7% |
| Education | $24.39 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,646 | 112 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,385 | 94 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $615.37 | 34 | $0 (2024) |
| Ardelyx, Inc. | $612.19 | 41 | $0 (2024) |
| GENZYME CORPORATION | $579.72 | 20 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $395.57 | 15 | $0 (2024) |
| Celgene Corporation | $350.65 | 21 | $0 (2024) |
| QOL Medical, LLC | $335.66 | 14 | $0 (2024) |
| Merck Sharp & Dohme LLC | $290.75 | 14 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $238.88 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,687 | 202 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($590.34) |
| 2023 | $3,547 | 202 | ABBVIE INC. ($650.74) |
| 2022 | $1,509 | 89 | ABBVIE INC. ($444.62) |
All Payment Transactions
493 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/16/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/13/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: Gastroenterology | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $8.96 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.32 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $7.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.97 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Rare Disease | ||||||
| 12/03/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Gastroenterology | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $4.82 | General |
| Category: Gastroenterology | ||||||
| 11/25/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/25/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: LIVER DISEASE | ||||||
| 11/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.98 | General |
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.28 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/19/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Immunology | ||||||
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $27.23 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $32.96 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: LIVER DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 352 | 464 | $104,591 | $28,786 |
| 2022 | 2 | 110 | 115 | $27,033 | $8,374 |
Total Patients
462
Total Services
579
Medicare Billing
$37,160
Procedure Codes
4
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 206 | 293 | $75,008 | $20,140 | 26.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 146 | 171 | $29,583 | $8,646 | 29.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 81 | 86 | $22,016 | $6,774 | 30.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 29 | $5,017 | $1,600 | 31.9% |
About Helena Benham
Helena Benham is a Family healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/24/2022. The National Provider Identifier (NPI) number assigned to this provider is 1639821473.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Helena Benham has received a total of $8,743 in payments from pharmaceutical and medical device companies, with $3,687 received in 2024. These payments were reported across 493 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($8,719).
As a Medicare-enrolled provider, Benham has provided services to 462 Medicare beneficiaries, totaling 579 services with total Medicare billing of $37,160. Data is available for 2 years (2022–2023), covering 4 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Louisville, KY
- Active Since 01/24/2022
- Last Updated 03/03/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1639821473
Products in Payments
- XIFAXAN (Drug) $993.92
- DUPIXENT (Biological) $838.49
- RINVOQ (Biological) $674.71
- IBSRELA (Drug) $612.19
- ZEPOSIA (Drug) $573.59
- ENTYVIO (Biological) $509.41
- TRULANCE (Drug) $369.51
- CREON (Drug) $298.93
- DIFICID (Drug) $290.75
- VIBERZI (Drug) $267.51
- Linzess (Drug) $234.01
- SUCRAID (Drug) $231.18
- XELJANZ (Drug) $206.45
- SKYRIZI (Biological) $184.68
- VOQUEZNA (Drug) $170.01
- LINZESS (Drug) $160.81
- Talicia (Drug) $155.11
- REBYOTA (Biological) $148.86
- OCALIVA (Drug) $145.30
- Wegovy (Drug) $144.77
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Louisville
Ruth Carrico, Rn, Msn, Phd, RN, MSN, PHD
Family — Payments: $403,371
Family $403,371
Ms. Smita Ranjan, Aprn, APRN
Family — Payments: $75,893
Family $75,893
Ashley Knable, Arnp, ARNP
Family — Payments: $75,423
Family $75,423
Danielle Revert, Aprn, APRN
Family — Payments: $64,469
Family $64,469
Mrs. Kassandra Green, Aprn, APRN
Family — Payments: $53,897
Family $53,897
Dr. Tracey Gaslin, Aprn, APRN
Family — Payments: $50,759
Family $50,759